Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
ROIC: Returns DecliningContracting
Percentile Rank29
Studio
Year-over-Year Change

Return on invested capital

Percentile
P29
Within normal range
vs 2Y Ago
-0.8x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
2025-222.48%+30.5%
2024-320.19%-208.8%
2023294.21%+203.7%
2022-283.65%-292.0%
2021-72.36%-161.3%
2020-27.69%+81.3%
2019-147.90%-49.0%
2018-99.23%+24.9%
2017-132.13%-92.7%
2016-68.57%-